Cargando…

Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

Detalles Bibliográficos
Autores principales: Verma, Megha, Beaulieu-Abdelahad, David, Ait-Ghezala, Ghania, Li, Rena, Crawford, Fiona, Mullan, Michael, Paris, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521847/
https://www.ncbi.nlm.nih.gov/pubmed/26230317
http://dx.doi.org/10.1371/journal.pone.0134776
_version_ 1782383869504258048
author Verma, Megha
Beaulieu-Abdelahad, David
Ait-Ghezala, Ghania
Li, Rena
Crawford, Fiona
Mullan, Michael
Paris, Daniel
author_facet Verma, Megha
Beaulieu-Abdelahad, David
Ait-Ghezala, Ghania
Li, Rena
Crawford, Fiona
Mullan, Michael
Paris, Daniel
author_sort Verma, Megha
collection PubMed
description
format Online
Article
Text
id pubmed-4521847
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45218472015-08-06 Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD Verma, Megha Beaulieu-Abdelahad, David Ait-Ghezala, Ghania Li, Rena Crawford, Fiona Mullan, Michael Paris, Daniel PLoS One Correction Public Library of Science 2015-07-31 /pmc/articles/PMC4521847/ /pubmed/26230317 http://dx.doi.org/10.1371/journal.pone.0134776 Text en © 2015 Verma et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Verma, Megha
Beaulieu-Abdelahad, David
Ait-Ghezala, Ghania
Li, Rena
Crawford, Fiona
Mullan, Michael
Paris, Daniel
Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title_full Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title_fullStr Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title_full_unstemmed Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title_short Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
title_sort correction: chronic anatabine treatment reduces alzheimer's disease (ad)-like pathology and improves socio-behavioral deficits in a transgenic mouse model of ad
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521847/
https://www.ncbi.nlm.nih.gov/pubmed/26230317
http://dx.doi.org/10.1371/journal.pone.0134776
work_keys_str_mv AT vermamegha correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT beaulieuabdelahaddavid correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT aitghezalaghania correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT lirena correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT crawfordfiona correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT mullanmichael correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad
AT parisdaniel correctionchronicanatabinetreatmentreducesalzheimersdiseaseadlikepathologyandimprovessociobehavioraldeficitsinatransgenicmousemodelofad